NanoViricides Shares Are Trading Higher After the Company Announced That It Ultra-broad-spectrum Antiviral NV-387 Was Found to Be Effective in Protecting Lungs From Damage in a Lethally Infected Influenza A H3N2 Mouse Model.
NanoViricides Shares Are Trading Higher After the Company Announced That It Ultra-broad-spectrum Antiviral NV-387 Was Found to Be Effective in Protecting Lungs From Damage in a Lethally Infected Influenza A H3N2 Mouse Model.
nanoviricides股票上漲，公司宣佈其超廣譜抗病毒藥物NV-387在致命感染的流感A H3N2小鼠模型中被發現對肺部損傷有保護作用。
NanoViricides Shares Are Trading Higher After the Company Announced That It Ultra-broad-spectrum Antiviral NV-387 Was Found to Be Effective in Protecting Lungs From Damage in a Lethally Infected Influenza A H3N2 Mouse Model.
nanoviricides股票上漲，公司宣佈其超廣譜抗病毒藥物NV-387在致命感染的流感A H3N2小鼠模型中被發現對肺部損傷有保護作用。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。